Search

Your search keyword '"Vijverberg, S.J.H. (Susanne)"' showing total 5 results
Start Over Author "Vijverberg, S.J.H. (Susanne)"
5 results on '"Vijverberg, S.J.H. (Susanne)"'

1. Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization (The Pharmacogenomics Journal, (2020), 10.1038/s41397-019-0140-y)

Author

King, C. (Charlotte), McKenna, A. (Amanda), Farzan, N. (Niloufar), Vijverberg, S.J.H. (Susanne), Schee, M.P. (Marc P.) van der, Maitland-van der Zee, A-H. (Anke-Hilse), Arianto, L. (Lambang), Bisgaard, H. (Hans), BØnnelykke, K. (Klaus), Berce, V. (Vojko), PotoČnik, U. (Uros), Repnik, K. (Katja), Carleton, B.C. (Bruce), Daley, D. (Denise), Chew, F.T. (Fook Tim), Chiang, W.C. (Wen Chin), Sio, Y.Y. (Yang Yie), Cloutier, M.M. (Michelle M.), Dekker, H.T. (Herman) den, Duijts, L. (Liesbeth), Jongste, J.C. (Johan) de, Dijk, F.N. (F. Nicole), Flores, C. (Carlos), Hernandez-Pacheco, N. (Natalia), Mukhopadhyay, S. (Somnath), Basu, K. (Kaninika), Tantisira, K.G. (Kelan G.), Verhamme, K.M.C. (Katia), Celedón, J.C. (Juan C.), Forno, E. (Erick), Canino, G. (Glorisa), Francis, B. (Ben), Pirmohamed, M. (Munir), Sinha, I. (Ian), Hawcutt, D.B. (Daniel B.), King, C. (Charlotte), McKenna, A. (Amanda), Farzan, N. (Niloufar), Vijverberg, S.J.H. (Susanne), Schee, M.P. (Marc P.) van der, Maitland-van der Zee, A-H. (Anke-Hilse), Arianto, L. (Lambang), Bisgaard, H. (Hans), BØnnelykke, K. (Klaus), Berce, V. (Vojko), PotoČnik, U. (Uros), Repnik, K. (Katja), Carleton, B.C. (Bruce), Daley, D. (Denise), Chew, F.T. (Fook Tim), Chiang, W.C. (Wen Chin), Sio, Y.Y. (Yang Yie), Cloutier, M.M. (Michelle M.), Dekker, H.T. (Herman) den, Duijts, L. (Liesbeth), Jongste, J.C. (Johan) de, Dijk, F.N. (F. Nicole), Flores, C. (Carlos), Hernandez-Pacheco, N. (Natalia), Mukhopadhyay, S. (Somnath), Basu, K. (Kaninika), Tantisira, K.G. (Kelan G.), Verhamme, K.M.C. (Katia), Celedón, J.C. (Juan C.), Forno, E. (Erick), Canino, G. (Glorisa), Francis, B. (Ben), Pirmohamed, M. (Munir), Sinha, I. (Ian), and Hawcutt, D.B. (Daniel B.)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Published
2020
Full Text
View/download PDF

2. Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation

Author

King, C. (Charlotte), McKenna, A. (Amanda), Farzan, N. (Niloufar), Vijverberg, S.J.H. (Susanne), Schee, M.P. (Marc P.) van der, Maitland-van der Zee, A-H. (Anke-Hilse), Arianto, L. (Lambang), Bisgaard, H. (Hans), BØnnelykke, K. (Klaus), Berce, V. (Vojko), Potočnik, U. (Uroš), Repnik, K. (Katja), Carleton, B.C. (Bruce), Daley, D. (Denise), Chew, F.T. (Fook Tim), Chiang, W.C. (Wen Chin), Sio, Y.Y. (Yang Yie), Cloutier, M.M. (Michelle M.), Dekker, H.T. (Herman) den, Duijts, L. (Liesbeth), Jongste, J.C. (Johan) de, Dijk, F.N. (F. Nicole), Koppelman, G.H. (Gerard), Flores, C. (Carlos), Hernandez-Pacheco, N. (Natalia), Pino-Yanes, M. (Maria), Mukhopadhyay, S. (Somnath), Basu, K. (Kaninika), Bignell, L. (Lauren), Tantisira, K.G. (Kelan G.), Turner, S.W. (Steve), Verhamme, K.M.C. (Katia), Francis, B. (Ben), Pirmohamed, M. (Munir), Sinha, I. (Ian), Hawcutt, D.B. (Daniel B.), King, C. (Charlotte), McKenna, A. (Amanda), Farzan, N. (Niloufar), Vijverberg, S.J.H. (Susanne), Schee, M.P. (Marc P.) van der, Maitland-van der Zee, A-H. (Anke-Hilse), Arianto, L. (Lambang), Bisgaard, H. (Hans), BØnnelykke, K. (Klaus), Berce, V. (Vojko), Potočnik, U. (Uroš), Repnik, K. (Katja), Carleton, B.C. (Bruce), Daley, D. (Denise), Chew, F.T. (Fook Tim), Chiang, W.C. (Wen Chin), Sio, Y.Y. (Yang Yie), Cloutier, M.M. (Michelle M.), Dekker, H.T. (Herman) den, Duijts, L. (Liesbeth), Jongste, J.C. (Johan) de, Dijk, F.N. (F. Nicole), Koppelman, G.H. (Gerard), Flores, C. (Carlos), Hernandez-Pacheco, N. (Natalia), Pino-Yanes, M. (Maria), Mukhopadhyay, S. (Somnath), Basu, K. (Kaninika), Bignell, L. (Lauren), Tantisira, K.G. (Kelan G.), Turner, S.W. (Steve), Verhamme, K.M.C. (Katia), Francis, B. (Ben), Pirmohamed, M. (Munir), Sinha, I. (Ian), and Hawcutt, D.B. (Daniel B.)

Abstract

A systematic review of pharmacogenomic studies capturing adverse drug reactions (ADRs) related to asthma medications was undertaken, and a survey of Pharmacogenomics in Childhood Asthma (PiCA) consortia members was conducted. Studies were eligible if genetic polymorphisms were compared with suspected ADR(s) in a patient with asthma, as either a primary or secondary outcome. Five studies met the inclusion criteria. The ADRs and polymorphisms identified were change in lung function tests (rs1042713), adrenal suppression (rs591118), and decreased bone mineral density (rs6461639) and accretion (rs9896933, rs2074439). Two of these polymorphisms were replicated within the paper, but none had external replication. Priorities from PiCA consortia members (representing 15 institution in eight countries) for future studies were tachycardia (SABA/LABA), adrenal suppression/crisis and growth suppression (corticosteroids), sleep/behaviour disturbances (leukotriene receptor antagonists), and nausea and vomiting (theophylline). Future pharmacogenomic studies in asthma should collect relevant ADR data as well as markers of efficacy.

Published
2020
Full Text
View/download PDF

3. IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids

Author

Dijk, F.N. (F. Nicole), Vijverberg, S.J.H. (Susanne), Hernandez-Pacheco, N. (Natalia), Repnik, K. (Katja), Karimi, L. (Leila), Mitratza, M. (Marianna), Farzan, N. (Niloufar), Nawijn, M.C. (Martijn), Burchard, E.G. (Esteban), Engelkes, M. (Marjolein), Verhamme, K.M.C. (Katia), Potočnik, U. (Uroš), Pino-Yanes, M. (Maria), Postma, D.S. (Dirkje), Maitland-van der Zee, A-H. (Anke-Hilse), Koppelman, G.H. (Gerard), Dijk, F.N. (F. Nicole), Vijverberg, S.J.H. (Susanne), Hernandez-Pacheco, N. (Natalia), Repnik, K. (Katja), Karimi, L. (Leila), Mitratza, M. (Marianna), Farzan, N. (Niloufar), Nawijn, M.C. (Martijn), Burchard, E.G. (Esteban), Engelkes, M. (Marjolein), Verhamme, K.M.C. (Katia), Potočnik, U. (Uroš), Pino-Yanes, M. (Maria), Postma, D.S. (Dirkje), Maitland-van der Zee, A-H. (Anke-Hilse), and Koppelman, G.H. (Gerard)

Published
2019
Full Text
View/download PDF

4. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use

Author

Farzan, Niloufar, Vijverberg, S.J.H. (Susanne), Hernandez-Pacheco, N., Bel, E.H., Berce, Vojko, Bønnelykke, K., Bisgaard, H. (Hans), Burchard, E.G. (Esteban), Canino, G., Celedón, Juan Carlos, Chew, Fook Tim, Chiang, W.C., Cloutier, M.M., Forno, Erick, Francis, Ben, Hawcutt, Daniel B., Herrera-Luis, E., Kabesch, M. (Michael), Karimi, L. (Leila), Melén, E., Mukhopadhyay, S., Merid, S.K. (Simon Kebede), Palmer, C.N.A. (Colin), Pino-Yanes, Maria, Pirmohamed, M. (Munir), Potočnik, Uros, Repnik, Katja, Schieck, Maximilian, Sevelsted, A. (Astrid), Sio, Y.Y., Smyth, Rosalind L., Soares, Patricia, Söderhäll, C. (Cilla), Tantisira, K.G., Tavendale, R. (Roger), Tse, Sze Man, Turner, S.W. (Steve), Verhamme, K.M.C. (Katia), Maitland-van der Zee, A-H. (Anke-Hilse), Farzan, Niloufar, Vijverberg, S.J.H. (Susanne), Hernandez-Pacheco, N., Bel, E.H., Berce, Vojko, Bønnelykke, K., Bisgaard, H. (Hans), Burchard, E.G. (Esteban), Canino, G., Celedón, Juan Carlos, Chew, Fook Tim, Chiang, W.C., Cloutier, M.M., Forno, Erick, Francis, Ben, Hawcutt, Daniel B., Herrera-Luis, E., Kabesch, M. (Michael), Karimi, L. (Leila), Melén, E., Mukhopadhyay, S., Merid, S.K. (Simon Kebede), Palmer, C.N.A. (Colin), Pino-Yanes, Maria, Pirmohamed, M. (Munir), Potočnik, Uros, Repnik, Katja, Schieck, Maximilian, Sevelsted, A. (Astrid), Sio, Y.Y., Smyth, Rosalind L., Soares, Patricia, Söderhäll, C. (Cilla), Tantisira, K.G., Tavendale, R. (Roger), Tse, Sze Man, Turner, S.W. (Steve), Verhamme, K.M.C. (Katia), and Maitland-van der Zee, A-H. (Anke-Hilse)

Abstract

_To the Editor,_ Approximately 25% of the asthmatic children suffer from uncontrolled asthma despite regular use of inhaled corticosteroids (ICS). Variation within the 17q21 locus is the strongest genetic determinant for childhood‐onset asthma. Recently, the influence of this locus on treatment outcomes has been shown in several studies. The Pharmacogenomics in Childhood Asthma (PiCA) consortium is a multiethnic consortium that brings together data from ≥14 000 asthmatic children/young adults from 12 different countries to study the pharmacogenomics of uncontrolled asthma despite treatment. In 14 PiCA populations (with over 4000 asthmatic patients), we studied the association between variation in the 17q21 locus, and asthma exacerbations despite ICS use. We specifically focused on rs7216389, a single nucleotide polymorphism (SNP) in the 17q21 locus strongly associated with childhood asthma and initially identified by Moffatt et al. [...]

Published
2018
Full Text
View/download PDF

5. Early life antibiotic use and the risk of asthma and asthma exacerbations in children

Author

Ahmadizar, F. (Fariba), Vijverberg, S.J.H. (Susanne), Arets, H.G. (Hubertus), Boer, A.C. (Anton) de, Turner, S. (Steve), Devereux, M.P. (Michael ), Arabkhazaeli, A. (Ali), Soares, P. (Patricia), Mukhopadhyay, S. (Somnath), Garssen, J. (Johan), Palmer, C.N.A. (Colin), Jongste, J.C. (Johan) de, Jaddoe, V.W.V. (Vincent), Duijts, L. (Liesbeth), van Meel, E.R. (Evelien R.), Kraneveld, A.D. (Aletta), Maitland-van der Zee, A-H. (Anke-Hilse), Ahmadizar, F. (Fariba), Vijverberg, S.J.H. (Susanne), Arets, H.G. (Hubertus), Boer, A.C. (Anton) de, Turner, S. (Steve), Devereux, M.P. (Michael ), Arabkhazaeli, A. (Ali), Soares, P. (Patricia), Mukhopadhyay, S. (Somnath), Garssen, J. (Johan), Palmer, C.N.A. (Colin), Jongste, J.C. (Johan) de, Jaddoe, V.W.V. (Vincent), Duijts, L. (Liesbeth), van Meel, E.R. (Evelien R.), Kraneveld, A.D. (Aletta), and Maitland-van der Zee, A-H. (Anke-Hilse)

Abstract

Background: The use of antibiotic therapy early in life might influence the risk of developing asthma. Studies assessing the influence of early life antibiotic use on the risk of asthma exacerbations are limited, and the results are inconsistent. Therefore, the aim of this study was to assess the association between use of antibiotic during the first 3 years of life and the risk of developing childhood asthma and the occurrence of asthma exacerbations. Methods: Data from four large childhood cohorts were used; two population-based cohorts to study the risk of developing asthma: Generation R (n=7393, The Netherlands) and SEATON (n=891, Scotland, UK), and two asthma cohorts to assess the risk of asthma exacerbations: PACMAN (n=668, The Netherlands) and BREATHE (n=806, Scotland, UK). Odds ratios (ORs) were derived from logistic regression analysis within each database followed by pooling the results using a fixed- or random-effect model. Results: Antibiotic use in early life was associated with an increased risk of asthma in a meta-analysis of the Generation R and SEATON data (OR: 2.18, 95% CI: 1.04-4.60; I2: 76.3%). There was no association between antibiotic use in early life and risk of asthma exacerbations later in life in a meta-analysis of the PACMAN and BREATHE data (OR: 0.93, 95% CI: 0.65-1.32; I2: 0.0%). Conclusion: Children treated with antibiotic in the first 3 years of life are more likely to develop asthma, but there is no evidence that the exposure to antibiotic is associated with increased risk of asthma exacerbations.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results